Cargando…
Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389393/ https://www.ncbi.nlm.nih.gov/pubmed/36799802 http://dx.doi.org/10.1097/JS9.0000000000000095 |
| _version_ | 1785082290032869376 |
|---|---|
| author | Khani, Elnaz Entezari-Maleki, Taher |
| author_facet | Khani, Elnaz Entezari-Maleki, Taher |
| author_sort | Khani, Elnaz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10389393 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103893932023-08-01 Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ Khani, Elnaz Entezari-Maleki, Taher Int J Surg Commentaries Lippincott Williams & Wilkins 2023-01-27 /pmc/articles/PMC10389393/ /pubmed/36799802 http://dx.doi.org/10.1097/JS9.0000000000000095 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Commentaries Khani, Elnaz Entezari-Maleki, Taher Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ |
| title | Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ |
| title_full | Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ |
| title_fullStr | Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ |
| title_full_unstemmed | Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ |
| title_short | Commentary on ‘Implications of the SARS-CoV-2 subvariants BA.4 and BA.5’ |
| title_sort | commentary on ‘implications of the sars-cov-2 subvariants ba.4 and ba.5’ |
| topic | Commentaries |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389393/ https://www.ncbi.nlm.nih.gov/pubmed/36799802 http://dx.doi.org/10.1097/JS9.0000000000000095 |
| work_keys_str_mv | AT khanielnaz commentaryonimplicationsofthesarscov2subvariantsba4andba5 AT entezarimalekitaher commentaryonimplicationsofthesarscov2subvariantsba4andba5 |